We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Events
» Regulatory Affairs
Date Range:
All
Next 7 Days
Next Month
Next 3 Months
Next 6 Months
Archives
Regulatory Affairs
Webinar
Jan. 20, 2022
Enabling Proactive Quality Management Across Quality and Manufacturing
Read More
Webinar
Jan. 20, 2022
The Biden Administration’s FDA: A Remarkable 2021, What to Expect in 2022
Read More
Webinar
Feb. 16, 2022
Statistics and Data for Regulatory Professionals and Attorneys: Product Performance Evidence Made Easy
Read More
Webinar
Feb. 17, 2022
Gene & Cell Therapy Regulation: Comparability and Other New Developments
Read More
Webinar
Feb. 23, 2022
Supply Chain Solutions: How the Pharmaceutical Industry Can End In-Bound Issue
Read More
Download iCal
Subscribe to Calendar
Upcoming Events
18
Jan
A Look Ahead in 2022: Trends and Insights from Leading Experts
20
Jan
Enabling Proactive Quality Management Across Quality and Manufacturing
20
Jan
The Biden Administration’s FDA: A Remarkable 2021, What to Expect in 2022
15
Feb
Successful Strategies for Digital Health in 2022: Who’s Doing Digital Well and How You Can Get Started
16
Feb
Statistics and Data for Regulatory Professionals and Attorneys: Product Performance Evidence Made Easy
17
Feb
Gene & Cell Therapy Regulation: Comparability and Other New Developments
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Two Models of Oscor’s Destino Twist and Guidestar Recalled
Pfizer’s Combination COVID-19 Booster and Pneumococcal Vaccine Show Promise in Late-Stage Trial
Inivata’s RaDaR Assay for Molecular Residual Disease Earns CE Mark
Takeda’s and Denali’s Alzheimer’s Drug Hit With Clinical Hold
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
